Richard Day,
MD

Dr. Day, DIA’s first President from outside the US, is a practicing Rheumatologist and Clinical Pharmacologist, and Professor of Clinical Pharmacology. He was co-founder of Australia’s leading post-graduate degree in Drug Development at the University of New South Wales Medicine. Recognized for his research and leadership in support of the quality use of medicines, Dr. Day has been deeply involved in Australia’s National Medicines Policy, culminating in his Chairmanship of the Federal Pharmaceutical Health and Rational Use of Medicines Committee. His research focuses on enhancing safe use of medicines using best evidence, eHealth systems, and decision support tools. He has published over 400 peer-reviewed papers and is a Member of the Order of Australia.